Cellular immunotherapy for high grade gliomas: mathematical analysis deriving efficacious infusion rates based on patient requirements
DOI10.1137/08073740XzbMATH Open1211.37109MaRDI QIDQ3068620FDOQ3068620
Authors: Ofir Shukron, Natalie Kronik, Yuri Kogan, Urszula Foryś, Zvia Agur 
Publication date: 17 January 2011
Published in: SIAM Journal on Applied Mathematics (Search for Journal in Brave)
Recommendations
- The impact of immunotherapy on a glioma immune interaction model
- Quantifying the role of immunotherapeutic drug T11 target structure in progression of malignant gliomas: mathematical modeling and dynamical perspective
- Stability analysis of a mathematical model for glioma-immune interaction under optimal therapy
- A strategy of optimal efficacy of T11 target structure in the treatment of brain tumor
- Tumor control, elimination, and escape through a compartmental model of dendritic cell therapy for melanoma
ordinary differential equationglioblastomamathematical modelsteady stateT celllocal and global stability analysis
Medical applications (general) (92C50) Qualitative investigation and simulation of ordinary differential equation models (34C60) Dynamical systems in biology (37N25) General biology and biomathematics (92B05)
Cited In (23)
- CAR T cells for T-cell leukemias: insights from mathematical models
- On a discrete model of tumour-immune system interactions with blockade of immune checkpoints
- Thresholds for extinction and proliferation in a stochastic tumour-immune model with pulsed comprehensive therapy
- The impact of immunotherapy on a glioma immune interaction model
- A mathematical model for a T cell fate decision algorithm during immune response
- Additional extension of the mathematical model for BCG immunotherapy of bladder cancer and its validation by auxiliary tool
- Global stability and parameter analysis reinforce therapeutic targets of PD-L1-PD-1 and MDSCs for glioblastoma
- Logistic tumor growth with delay and impulsive treatment
- An immune system-tumour interactions model with discrete time delay: model analysis and validation
- Quantifying the role of immunotherapeutic drug T11 target structure in progression of malignant gliomas: mathematical modeling and dynamical perspective
- On the analysis of a mathematical model of CAR-T cell therapy for glioblastoma: insights from a mathematical model
- Dynamics of tumor-\( \text{CD}4^+\)-cytokine-host cells interactions with treatments
- Asymptotic dynamics of some \(t\)-periodic one-dimensional model with application to prostate cancer immunotherapy
- Study of dose-dependent combination immunotherapy using engineered T cells and IL-2 in cervical cancer
- About a generalized model of lymphoma
- Optimal control for a mathematical model of glioma treatment with oncolytic therapy and TNF-\(\alpha \) inhibitors
- Tractable model of malignant gliomas immunotherapy with discrete time delays
- A mathematical model of the enhancement of tumor vaccine efficacy by immunotherapy
- Analysis of the Hopf bifurcation for the family of angiogenesis models. II: The case of two nonzero unequal delays
- Modelling pulsed immunotherapy of tumour-immune interaction
- Modelling effects of a chemotherapeutic dose response on a stochastic tumour-immune model
- A structural methodology for modeling immune-tumor interactions including pro- and anti-tumor factors for clinical applications
- Modeling CAR T-cell therapy with patient preconditioning
This page was built for publication: Cellular immunotherapy for high grade gliomas: mathematical analysis deriving efficacious infusion rates based on patient requirements
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3068620)
